[A case of advanced gastric cancer showing a complete histological response after S-1/CDDP neoadjuvant chemotherapy]. 2011

Tatsunori Kobayashi, and Yasuhiro Kubota, and Satoshi Ueyama, and Kazutaka Satomoto, and Tetsuya Ogino
Dept. of Surgery, Mihara Red Cross Hospital.

We experienced a case of advanced gastric cancer treated by curative operation after neoadjuvant chemotherapy with S-1/ CDDP. Gastric endoscopy was carried out on a 76-year-old man with epigastric discomfort and revealed a type 1 lesion in his stomach. Papillary adenocarcinoma was pathologically shown by endoscopic biopsy. The patient was initially treated by two courses of neoadjuvant chemotherapy with S-1/CDDP due to the large lymph node metastases around the lesser curvature of the stomach and celiac axis. Completion of chemotherapy resulted in a marked shrinkage of the primary lesion and a reduction of lymph node metastases. Later, total gastrectomy, splenectomy and D2 lymph node dissection were performed. Histopathological examination revealed no cancer cells in either the primary lesion of the stomach or dissected lymph nodes, confirming a pathologically complete response.

UI MeSH Term Description Entries
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008297 Male Males
D010094 Oxonic Acid Antagonist of urate oxidase. Oteracil
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005641 Tegafur Congener of FLUOROURACIL with comparable antineoplastic action. It has been suggested especially for the treatment of breast neoplasms. 1-(2-Tetrahydrofuryl)-5-fluorouracil,1-(Tetrahydro-2-furanyl)-5-fluorouracil,5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione,FT-207,FT207,Florafur,Fluorofur,Ftorafur,Futraful,N1-(2'-Tetrahydrofuryl)-5-fluorouracil,Sunfural S,Uftoral,Utefos,FT 207
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies

Related Publications

Tatsunori Kobayashi, and Yasuhiro Kubota, and Satoshi Ueyama, and Kazutaka Satomoto, and Tetsuya Ogino
March 2019, Gan to kagaku ryoho. Cancer & chemotherapy,
Tatsunori Kobayashi, and Yasuhiro Kubota, and Satoshi Ueyama, and Kazutaka Satomoto, and Tetsuya Ogino
December 2007, Gan to kagaku ryoho. Cancer & chemotherapy,
Tatsunori Kobayashi, and Yasuhiro Kubota, and Satoshi Ueyama, and Kazutaka Satomoto, and Tetsuya Ogino
November 2009, Gan to kagaku ryoho. Cancer & chemotherapy,
Tatsunori Kobayashi, and Yasuhiro Kubota, and Satoshi Ueyama, and Kazutaka Satomoto, and Tetsuya Ogino
January 2015, Gan to kagaku ryoho. Cancer & chemotherapy,
Tatsunori Kobayashi, and Yasuhiro Kubota, and Satoshi Ueyama, and Kazutaka Satomoto, and Tetsuya Ogino
August 2011, Gan to kagaku ryoho. Cancer & chemotherapy,
Tatsunori Kobayashi, and Yasuhiro Kubota, and Satoshi Ueyama, and Kazutaka Satomoto, and Tetsuya Ogino
November 2010, Gan to kagaku ryoho. Cancer & chemotherapy,
Tatsunori Kobayashi, and Yasuhiro Kubota, and Satoshi Ueyama, and Kazutaka Satomoto, and Tetsuya Ogino
April 2010, Gan to kagaku ryoho. Cancer & chemotherapy,
Tatsunori Kobayashi, and Yasuhiro Kubota, and Satoshi Ueyama, and Kazutaka Satomoto, and Tetsuya Ogino
January 2009, Gan to kagaku ryoho. Cancer & chemotherapy,
Tatsunori Kobayashi, and Yasuhiro Kubota, and Satoshi Ueyama, and Kazutaka Satomoto, and Tetsuya Ogino
January 2006, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,
Tatsunori Kobayashi, and Yasuhiro Kubota, and Satoshi Ueyama, and Kazutaka Satomoto, and Tetsuya Ogino
November 2011, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!